A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease

Yu Nakamura(Kyorin University), Akira Homma(Tokyo Health Care University), Kazuma Nishimura(Ono Pharmaceutical (Japan)), Shoichiro Oda(Ono Pharmaceutical (Japan)), Christine Strohmaier(Novartis (Switzerland)), Naoko Kataoka(Novartis (Switzerland)), Masayuki Nakano(Nihon University), Kaoru Tamura(Tokyo Medical and Dental University)

Dementia and Geriatric Cognitive Disorders Extra

September 28, 2015

Cited by 11

|Radiology|2011|354

|Hepatology|2018|333

|Cancer|1977|262

|Gastroenterology|1982|249

|Gastroenterology|2007|202

Related Papers